Jeffrey Berger A study of 9 000 women with established cardiovascular disease has found that mortality is reduced by 25 per cent among those taking aspirin, and that the dose of daily aspirin does not
Jeffrey Berger
A study of 9 000 women with established cardiovascular disease has found that mortality is reduced by 25 per cent among those taking aspirin, and that the dose of daily aspirin does not affect this result.Jeffrey Bergerof Duke University Medical Center told us more about it.
Tags
Related Episodes
CHARISMA Trial: Add Clopidogrel to Aspirin? Not for Lower Risk Patients
Deepak Bhatt, Cleveland Clinic, Ohio American College of Cardiology Annual Scientific Session March 11-14, 2006, Atlanta The idea of adding clopidogrel anti-platelet therapy to standard aspirin therap
Stroke Prevention: Aspirin is Different in Women
David Brown The effect of aspirin in preventing cerebrovascular disease is different in women as compared with men. A meta-analysis of six studies presented at the AHA meeting by David Brown shows tha
Warfarin Trumps Platelet Agents in Atrial Fibrilation
For atrial fibrillation, oral anti-coagulation remains the treatment of choice despite the potential of an anti-platelet regimen based on aspirin and clopidogrel, according to the ACTIVE-W trial. Stua